Acute Myocardial Infarction
Research Maatschap Cardiologen Rotterdam Zuid focuses on clinical research in ST-elevated myocardial infarction, with interest in treatment strategies for patients undergoing primary PCI and subsequent coronary care.
- ST-elevated myocardial infarction
- Primary percutaneous coronary intervention
- Post-infarction coronary management
The sponsor’s research activity is centered on optimizing care pathways for acute coronary events in patients with complex coronary disease.
Antiplatelet Therapy
The trial portfolio includes interest in dual antiplatelet therapy strategies, particularly abbreviated treatment followed by P2Y12 inhibitor monotherapy with prasugrel in patients recovering from myocardial infarction.
- Dual antiplatelet therapy
- Prasugrel
- P2Y12 inhibitor monotherapy
This area reflects a therapeutic focus on balancing ischemic protection and bleeding risk in coronary patients.
Coronary Revascularization
Research activity also extends to revascularization completion after the initial infarction procedure, with attention to treatment decisions in patients with multivessel coronary artery disease.
- Multivessel coronary artery disease
- Complete revascularization
- Coronary intervention strategy
The sponsor is involved in clinical questions surrounding how best to manage residual coronary lesions after acute intervention.
Intravascular Imaging
The funded research includes use of optical coherence tomography to guide coronary treatment decisions, with a focus on imaging-based assessment of stent results and vessel optimization.
- Optical coherence tomography
- Stent optimization
- Minimal stent area
This reflects a therapeutic interest in image-guided coronary intervention and procedural refinement in patients with complex infarction-related disease.
